Showing 1091-1100 of 18563 results for "".
The Regulatory Environment for the Artificial Pancreas
https://reachmd.com/programs/diabetes-discourse/the-regulatory-environment-for-the-artificial-pancreas/6500/The artificial pancreas project lead by the Juvenile Diabetes Research Foundation has made tremendous progress towards eventual outpatient clinical studies. A recent panel of experts met with the FDA and NIH to determine appropriate guidelines. What are regulatory guidelines for the artificial panOptimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
https://reachmd.com/programs/eye-on-ocular-health/optimizing-anti-vegf-sequencing-strategies-to-reduce-burden-and-personalize-care/36259/As the anti-VEGF landscape continues to expand, so do the opportunities to fine-tune treatment strategies for retinal conditions like age-related macular degeneration and diabetic macular edema. To learn more about how we can personalize therapy by leveraging newer agents with greater durability, asCurrent & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults
https://reachmd.com/programs/cme/current-emerging-therapies-treating-preventing-hereditary-angioedema-attacks-in-children-adults/37604/Provided by RMEI Medical Education, LLC. Supported by independent educational grants from Intellia Therapeutics, Pharming Healthcare, Inc., and Pharvaris.Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
https://reachmd.com/programs/project-oncology/oral-contraceptives-and-endometrial-cancer-examining-a-potential-dose-response-protective-effect/35506/As rates of endometrial cancer rise globally, a 2025 meta-analysis offers compelling evidence that oral contraceptives (OCs) could significantly reduce EMC risk. Explore the findings from this new review and its potential implications for the future of patient care.The Far-Reaching Impacts of Psoriasis: Understanding and Mitigating Risks
https://reachmd.com/programs/dermconsult/the-far-reaching-impacts-of-psoriasis-understanding-and-mitigating-risks/32452/Hear how psoriasis can impact a patient’s health beyond their skin and how to best support them to improve outcomes and minimize risks.Measuring IgAN Risk: Genetic, Environmental, and Systemic Factors
https://reachmd.com/programs/clinicians-roundtable/measuring-igan-risk-genetic-environmental-and-systemic-factors/29742/Learn about common risk factors for IgA nephropathy.Deciphering IgA Nephropathy: Insights into the Diagnostic Process
https://reachmd.com/programs/frontlines-iga-nephropathy/deciphering-iga-nephropathy-insights-into-the-diagnostic-process/26946/When IgA nephropathy is suspected, it’s important to follow a stepwise pattern to confirm those suspicions. Here’s what the diagnostic process looks like.How MR Fingerprinting Is Transforming Epilepsy Imaging, Surgical Evaluation, and Outcome Prediction
https://reachmd.com/programs/practical-neurology/how-mr-fingerprinting-is-transforming-epilepsy-imaging-surgical-evaluation-and-outcome-prediction/39909/Irene Wang, PhD, Cleveland Clinic, Cleveland, OH, describes how MR fingerprinting, a novel quantitative MRI technique, improves lesion detection, tissue characterization, and presurgical evaluation in patients with drug-resistant epilepsy.AI and Hair Loss: Measuring Progress with Data-Driven Insights
https://reachmd.com/programs/clinicians-roundtable/ai-and-hair-loss-measuring-progress-with-data-driven-insights/32933/Explore how devices powered by artificial intelligence can impact the way dermatologists track hair loss through precise data.Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
https://reachmd.com/programs/living-rheum/recognizing-and-addressing-rheumatic-iraes-from-cancer-immunotherapies/32791/Patients who are receiving immunotherapy for cancer sometimes develop significant autoimmune complications, which can be fatal. Join Dr. Laura Cappelli, Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine, as she explains how multidisciplinary collaboratio